BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15122087)

  • 1. Gastro-intestinal hormones GIP and GLP-1.
    Kieffer TJ
    Ann Endocrinol (Paris); 2004 Feb; 65(1):13-21. PubMed ID: 15122087
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of incretin hormones.
    Efendic S; Portwood N
    Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 and control of insulin secretion.
    Thorens B
    Diabete Metab; 1995 Dec; 21(5):311-8. PubMed ID: 8586147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [GIP and GLP-1: multiplicity of regulator mechanisms for insulin secretion].
    Thorens B
    Journ Annu Diabetol Hotel Dieu; 2004; ():111-25. PubMed ID: 15259310
    [No Abstract]   [Full Text] [Related]  

  • 5. Incretin hormones and insulin secretion.
    Ahrén B; Gromada J; Schmitz O
    Horm Metab Res; 2004; 36(11-12):733-4. PubMed ID: 15655700
    [No Abstract]   [Full Text] [Related]  

  • 6. Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes.
    Nauck MA; Baller B; Meier JJ
    Diabetes; 2004 Dec; 53 Suppl 3():S190-6. PubMed ID: 15561910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Regul Pept; 2003 Jul; 114(2-3):115-21. PubMed ID: 12832099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incretins, insulin secretion and Type 2 diabetes mellitus.
    Vilsbøll T; Holst JJ
    Diabetologia; 2004 Mar; 47(3):357-366. PubMed ID: 14968296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.
    Vahl T; D'Alessio D
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):461-8. PubMed ID: 12806222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility.
    Miki T; Minami K; Shinozaki H; Matsumura K; Saraya A; Ikeda H; Yamada Y; Holst JJ; Seino S
    Diabetes; 2005 Apr; 54(4):1056-63. PubMed ID: 15793244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review: regulation of glucose metabolism].
    Yamada Y; Seino Y
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():153-8. PubMed ID: 12238041
    [No Abstract]   [Full Text] [Related]  

  • 13. [Digestive tract hormones and pancreatic secretion].
    Shima K
    Nihon Naibunpi Gakkai Zasshi; 1990 Dec; 66(12):1228-35. PubMed ID: 2292313
    [No Abstract]   [Full Text] [Related]  

  • 14. The metabolic role of GIP: physiology and pathology.
    Morgan LM
    Biochem Soc Trans; 1996 May; 24(2):585-91. PubMed ID: 8736808
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gluco-incretin hormones in insulin secretion and diabetes].
    Thorens B
    Med Sci (Paris); 2003; 19(8-9):860-3. PubMed ID: 14593618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.
    Patriti A; Facchiano E; Sanna A; Gullà N; Donini A
    Obes Surg; 2004; 14(6):840-8. PubMed ID: 15318993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus.
    Meier JJ; Gallwitz B; Nauck MA
    BioDrugs; 2003; 17(2):93-102. PubMed ID: 12641488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.
    Creutzfeldt W
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapancreatic effects of GIP and GLP-1.
    Vella A; Rizza RA
    Horm Metab Res; 2004; 36(11-12):830-6. PubMed ID: 15655715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endocrine system of the gastrointestinal tract. Pathophysiology with a clinical view].
    Skrha J
    Vnitr Lek; 2004 May; 50(5):392-8. PubMed ID: 15305639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.